TOXOPLASMA GONDII IGG— 510(k) K902792

Name: FDA 510(k) clearance K902792
Creator: U.S. Food and Drug Administration
Published: 1990-07-24

Substantially Equivalent

Pharmacia Diagnostics, Inc.

FDA 510(k) clearance K902792 for TOXOPLASMA GONDII IGG, Substantially Equivalent on 1990-07-24. Applicant: Pharmacia Diagnostics, Inc.. Device class: 2.

Clearance details

Applicant: Pharmacia Diagnostics, Inc.
Product code: Code LGD
Device class: Class 2
Regulation: 21 CFR 866.3780
Advisory panel: Microbiology
Date received: 1990-06-26
Decision date: 1990-07-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Columbia, MD, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LGD

view all

K242022 — Access Toxo IgG2025-03-28
K242095 — Access Toxo IgM II2024-10-11
K233932 — Alinity i Toxo IgM2024-08-30
K210596 — ARCHITECT Toxo IgG2022-05-19
K162678 — Elecsys Toxo IgM, Elecsys Toxo IgM PreciControl2017-06-23

More clearances from Pharmacia Diagnostics, Inc.

view all

K921011 — PHARMACIA CMV IGM ELISA1992-07-27
K920702 — TOXOPLASMA GONDII (TOXO) IGM ENZYME-LINKED IMMUNO1992-07-08
K915348 — EBV-VCA IGM ELISA1992-02-14
K914022 — SERIOLOGICAL TEST KIT/IGM ANTIBODY VARI-ZOST VIRUS1992-01-27
K912026 — DELFIA(R) 17 -OH-PROGESTERON KIT1991-06-25

Adverse events under product code LGD

product code LGD

Malfunction: 502
Total: 502

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.